dermoplast post partum

Generic: benzocaine

Labeler: advantice health, llc
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name dermoplast post partum
Generic Name benzocaine
Labeler advantice health, llc
Dosage Form AEROSOL, SPRAY
Routes
TOPICAL
Active Ingredients

benzocaine 200 mg/g

Manufacturer
Advantice Health, LLC

Identifiers & Regulatory

Product NDC 16864-640
Product ID 16864-640_374dced3-6528-b458-e063-6394a90a911e
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M015
Listing Expiration 2026-12-31
Marketing Start 2025-01-01

Pharmacologic Class

Established (EPC)
standardized chemical allergen [epc]
Chemical Structure
allergens [cs]
Physiologic Effect
increased histamine release [pe] cell-mediated immunity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 16864640
Hyphenated Format 16864-640

Supplemental Identifiers

RxCUI
211316 360349
UPC
0316864640017
UNII
U3RSY48JW5
NUI
N0000185508 N0000175629 N0000184306 M0000728

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name dermoplast post partum (source: ndc)
Generic Name benzocaine (source: ndc)
Application Number M015 (source: ndc)
Routes
TOPICAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/g
source: ndc
Packaging
  • 78 g in 1 CAN (16864-640-01)
source: ndc

Packages (1)

Ingredients (1)

benzocaine (200 mg/g)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "374dced3-6528-b458-e063-6394a90a911e", "openfda": {"nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "upc": ["0316864640017"], "unii": ["U3RSY48JW5"], "rxcui": ["211316", "360349"], "spl_set_id": ["374dced3-6527-b458-e063-6394a90a911e"], "pharm_class_cs": ["Allergens [CS]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "manufacturer_name": ["Advantice Health, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "78 g in 1 CAN (16864-640-01)", "package_ndc": "16864-640-01", "marketing_start_date": "20250101"}], "brand_name": "Dermoplast Post Partum", "product_id": "16864-640_374dced3-6528-b458-e063-6394a90a911e", "dosage_form": "AEROSOL, SPRAY", "pharm_class": ["Allergens [CS]", "Cell-mediated Immunity [PE]", "Increased Histamine Release [PE]", "Standardized Chemical Allergen [EPC]"], "product_ndc": "16864-640", "generic_name": "BENZOCAINE", "labeler_name": "Advantice Health, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Dermoplast Post Partum", "active_ingredients": [{"name": "BENZOCAINE", "strength": "200 mg/g"}], "application_number": "M015", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20250101", "listing_expiration_date": "20261231"}